6949 — Pell Bio Med Technology Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for Pell Bio Med Technology Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-189	-231	-401	-395	-453
Depreciation
Amortisation
Non-Cash Items	26.4	45.8	138	46.6	60.2
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	24.5	-6.59	37.6	41.5	64
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-108	-161	-180	-260	-281
Capital Expenditures	-14.5	-8.49	-16.5	-264	-228
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	98.4	-542	-403	168	-270
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	83.9	-551	-420	-95.5	-497
Financing Cash Flow Items	—	15	0	110	216
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-5.23	769	595	615	658
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-29.2	56.6	-4.73	260	-121